In Vivo Activities of Farnesyl Pyrophosphate Synthase Inhibitors against Leishmania donovani and Toxoplasma gondii

The in vivo activities of three bisphosphonates were determined against Leishmania donovani and Toxoplasma gondii. Alendronate was essentially inactive against both parasites. Pamidronate was active against L. donovani by intravenous administration. Risedronate had a 50% effective dosage of five 2.6...

詳細記述

書誌詳細

出版年:	Antimicrob Agents Chemother
主要な著者:	Yardley, Vanessa, Khan, Anis A., Martin, Michael B., Slifer, Teri R., Araujo, Fausto G., Moreno, Silvia N. J., Docampo, Roberto, Croft, Simon L., Oldfield, Eric
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 2002
主題:	Experimental Therapeutics
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127510/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11850291/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.3.929-931.2002
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!